Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Other Working Capital Changes (2023 - 2025)

Historic Other Working Capital Changes for Immunome (IMNM) over the last 3 years, with Q3 2025 value amounting to $237184.0.

  • Immunome's Other Working Capital Changes rose 15.88% to $237184.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $237184.0, marking a year-over-year increase of 15.88%. This contributed to the annual value of $390488.0 for FY2024, which is 60143.34% up from last year.
  • Per Immunome's latest filing, its Other Working Capital Changes stood at $237184.0 for Q3 2025, which was up 15.88% from $223382.0 recorded in Q2 2025.
  • Over the past 5 years, Immunome's Other Working Capital Changes peaked at $27.6 million during Q1 2023, and registered a low of -$3.8 million during Q4 2023.
  • For the 3-year period, Immunome's Other Working Capital Changes averaged around $2.0 million, with its median value being $111130.0 (2025).
  • Over the last 5 years, Immunome's Other Working Capital Changes had its largest YoY gain of 74781.59% in 2024, and its largest YoY loss of 9965.77% in 2024.
  • Over the past 3 years, Immunome's Other Working Capital Changes (Quarter) stood at -$3.8 million in 2023, then increased by 28.44% to -$2.7 million in 2024, then soared by 108.66% to $237184.0 in 2025.
  • Its Other Working Capital Changes stands at $237184.0 for Q3 2025, versus $223382.0 for Q2 2025 and $111130.0 for Q1 2025.